Importance of field cancerisation in clinical oncology
Authors:
- Jean-Nicolas VautheyJVJean-Nicolas Vauthey
- Garrett L WalshGWGarrett L Walsh
- Georges VlastosGVGeorges Vlastos
- Gregory Y LauwersGLGregory Y Lauwers
- 1 September 2000
- journal article
- other
- Published by Elsevier in The Lancet Oncology
- Vol. 1 (1) , 15-16
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinomaCancer, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 1998
- Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisThe Lancet, 1995
- Factors affecting long-term outcome after hepatic resection for hepatocellular carcinomaThe American Journal of Surgery, 1995